Minoryx TherapeuticsListed
minoryx.combiotech_life_sciences
Minoryx Therapeutics is a clinical stage biotech company focused on the discovery and development of innovative treatments for orphan CNS diseases, particularly X-linked Adrenoleu…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Minoryx Therapeutics is a clinical stage biotech company focused on the discovery and development of innovative treatments for orphan CNS diseases, particularly X-linked Adrenoleu…
Astrivax Therapeutics is a clinical-stage biopharmaceutical company on a mission to end virus-driven cancer, the second leading preventable cause of cancer after smoking. Its clin…
Coave Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS and eye diseases using its proprietary ALIGATER platform, w…
Immunic is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, focusing on chronic inflammatory and autoimmune diseases.
eTheRNA Immunotherapies is a biotech company specializing in mRNA and lipid-based nanoparticle (LNP) technologies for the development of nucleic acid-based therapeutics. They part…
Cellaion is a Belgium-based biotechnology research company focused on cell signaling for organ repair and regeneration, with a particular emphasis on liver health. The company dev…
EPICS Therapeutics is a clinical-stage biotechnology company pioneering therapies that target RNA epigenetic regulation, focusing on small-molecule modulators to transform cancer…
Confo Therapeutics is a clinical-stage biotech company focused on accelerating novel medicines for metabolic and endocrine diseases using its proprietary GPCR-targeting technology.
EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with innovative sustained release micro-impla…
Indigo Diabetes is developing the world’s first continuous multi-metabolite monitoring (CMM®) system for people living with chronic diseases, initially focusing on diabetes manage…
ExeVir develops novel antibody therapies capable of preventing and treating current public health threats and responding to future outbreaks with speed and agility. Their unique m…
Egle Therapeutics is a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory T cells (Tregs) to rebalance immune function in patients with a…
TargED Biopharmaceuticals B.V. is a Netherlands based biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. Their unique biologic…
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos T…
Octimet Oncology conducts biotechnology research and develops oncology pharmaceuticals. The Company focuses on preclinical and clinical research, business development for drug com…
Ogeda is a drug discovery business that developed Fezolinetant, a non-hormonal treatment for women's disorders such as hot flashes and uterine fibroids. The company was acquired b…
qBiologicals is a Belgian company specialized in bioprocess development and biomanufacturing, focusing on providing services for the development of human and veterinary drugs.
Cardior Pharmaceuticals is a pioneering biopharmaceutical company focused on discovering and developing RNA-based therapeutics to address the root causes of heart disease. Their m…
Tubulis generates uniquely matched antibody-drug conjugates with superior biophysical properties that have demonstrated durable on-tumor delivery and long-lasting anti-tumor activ…
Novadip is advancing the standard of care in bone and tissue regenerative medicine, focusing on developing a new class of regenerative tissue products that accelerate healing of l…
Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renow…